Reshaping of Italian Echocardiographic Laboratories Activities during the Second Wave of COVID-19 Pandemic and Expectations for the Post-Pandemic Era.
COVID-19
lung ultrasound
point-of-care cardiac ultrasound
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
05 Aug 2021
05 Aug 2021
Historique:
received:
07
07
2021
revised:
26
07
2021
accepted:
30
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Cardiology divisions reshaped their activities during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to analyze the organization of echocardiographic laboratories and echocardiography practice during the second wave of the COVID-19 pandemic in Italy, and the expectations for the post-COVID era. We analyzed two different time periods: the month of November during the second wave of the COVID-19 pandemic (2020) and the identical month during 2019 (November 2019). During the second wave of the COVID-19 pandemic, the hospital activity was partially reduced in 42 (60%) and wholly interrupted in 3 (4%) echocardiographic laboratories, whereas outpatient echocardiographic activity was partially reduced in 41 (59%) and completely interrupted in 7 (10%) laboratories. We observed an important change in the organization of activities in the echocardiography laboratory which reduced the operator-risk and improved self-protection of operators by using appropriate personal protection equipment. Operators wore FFP2 in 58 centers (83%) during trans-thoracic echocardiography (TTE), in 65 centers (93%) during transesophageal echocardiography (TEE) and 63 centers (90%) during stress echocardiography. The second wave caused a significant reduction in number of echocardiographic exams, compared to November 2019 (from 513 ± 539 to 341 ± 299 exams per center, -34%, In one year, major changes occurred in echocardiography practice and culture. The examination structure changed with extensive usage of point-of-care cardiac ultrasound and with lung ultrasound embedded by default in the TTE examination, as well as the COVID-19 testing.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiology divisions reshaped their activities during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to analyze the organization of echocardiographic laboratories and echocardiography practice during the second wave of the COVID-19 pandemic in Italy, and the expectations for the post-COVID era.
METHODS
METHODS
We analyzed two different time periods: the month of November during the second wave of the COVID-19 pandemic (2020) and the identical month during 2019 (November 2019).
RESULTS
RESULTS
During the second wave of the COVID-19 pandemic, the hospital activity was partially reduced in 42 (60%) and wholly interrupted in 3 (4%) echocardiographic laboratories, whereas outpatient echocardiographic activity was partially reduced in 41 (59%) and completely interrupted in 7 (10%) laboratories. We observed an important change in the organization of activities in the echocardiography laboratory which reduced the operator-risk and improved self-protection of operators by using appropriate personal protection equipment. Operators wore FFP2 in 58 centers (83%) during trans-thoracic echocardiography (TTE), in 65 centers (93%) during transesophageal echocardiography (TEE) and 63 centers (90%) during stress echocardiography. The second wave caused a significant reduction in number of echocardiographic exams, compared to November 2019 (from 513 ± 539 to 341 ± 299 exams per center, -34%,
CONCLUSIONS
CONCLUSIONS
In one year, major changes occurred in echocardiography practice and culture. The examination structure changed with extensive usage of point-of-care cardiac ultrasound and with lung ultrasound embedded by default in the TTE examination, as well as the COVID-19 testing.
Identifiants
pubmed: 34441762
pii: jcm10163466
doi: 10.3390/jcm10163466
pmc: PMC8397129
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Am Coll Radiol. 2018 Oct;15(10):1385-1393
pubmed: 30158086
Heart. 2011 Jul;97(14):1128-31
pubmed: 21685481
J Cardiovasc Echogr. 2020 Oct;30(Suppl 2):S1-S5
pubmed: 33489729
Eur Heart J Cardiovasc Imaging. 2020 Jun 1;21(6):592-598
pubmed: 32242891
BMJ. 2020 Jul 14;370:m2752
pubmed: 32665257
JACC Cardiovasc Imaging. 2018 Nov;11(11):1692-1705
pubmed: 30409330
Int J Cardiol. 2018 Mar 15;255:231-236
pubmed: 29288056
J Cardiovasc Med (Hagerstown). 2021 Jul 1;22(7):600-602
pubmed: 34076607
JACC Cardiovasc Imaging. 2020 Jul;13(7):1615-1626
pubmed: 32646721
J Med Ultrason (2001). 2021 Jan;48(1):31-43
pubmed: 33438132
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
Eur Heart J. 2020 Jun 14;41(23):2146-2147
pubmed: 32556332
J Am Soc Echocardiogr. 2020 Apr;33(4):409-422.e4
pubmed: 32122742
Eur Heart J. 2021 Mar 7;42(10):961-962
pubmed: 33693577
J Am Soc Echocardiogr. 2020 Jun;33(6):690-691
pubmed: 32503708
Eur Heart J Cardiovasc Imaging. 2020 Sep 1;21(9):941-948
pubmed: 32515793
J Cardiovasc Echogr. 2020 Jan-Mar;30(1):2-4
pubmed: 32766099
J Am Soc Echocardiogr. 2020 Jun;33(6):648-653
pubmed: 32503700
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Environ Sci Pollut Res Int. 2021 Aug;28(30):41423-41430
pubmed: 33786763
Eur Heart J Cardiovasc Imaging. 2020 Sep 1;21(9):1057
pubmed: 32734283